Grouping approaches based on structure alone are insufficient to conclude about toxicological properties—the example of monoamine-based chelates

References

• Anderson RL, Kanerva RL. 1978. Hypercalcinuria and crystalluria during ingestion of dietary Nitrilotriacetate. Food Cosmet Toxicol. 16(6):569–574. doi: 10.1016/S0015-6264(78)80225-9.
   PubMedGoogle Scholar
• Anderson RL, Kanerva RL. 1979. Comparisons of response of Fischer-344 and Charles River rats to 1.5% nitrilotriacetic acid and 2% trisodium nitrilotriacetate, monohydrate. Food Cosmet Toxicol. 17(2):137–140. doi: 10.1016/0015-6264(79)90211-6.
   PubMedGoogle Scholar
• Anderson RL. 1980. The relationship of insoluble nitrilotriacetate (NTA) in the urine of female rats to the dietary level of NTA. Food Cosmet Toxicol. 18(1):59–64. doi: 10.1016/0015-6264(80)90012-7.
   PubMedGoogle Scholar
• Anderson RL. 1981. The role of zinc in nitriloacetate(NTA)-associated renal tubular cell toxicity. Food Cosmet Toxicol. 19(5):639–650. doi: 10.1016/0015-6264(81)90516-2.
   PubMedGoogle Scholar
• Anderson RL, Bishop WE, Campbell RL. 1985. A review of the environmental and mammalian toxicology of nitrilotriacetic acid. Crit Rev Toxicol. 15(1):1–102. doi: 10.3109/10408448509023766.
   PubMed Web of Science ®Google Scholar
• Anonymous. 1985. EDG. https://echa.europa.eu/registration-dossier/-/registered-dossier/11665/7/2/2 (unpublished report).
   Google Scholar
• Anonymous. 1986a. EDG. https://echa.europa.eu/registration-dossier/-/registered-dossier/11665/7/7/2/?documentUUID=3ad80f3a-9b9a-4ed0-8c7e-2af827bbc037) (unpublished report).
   Google Scholar
• Anonymous. 1986b. EDG. https://echa.europa.eu/registration-dossier/-/registered-dossier/11665/7/7/3 (unpublished report).
   Google Scholar
• Anonymous. 1987. EDG. https://echa.europa.eu/registration-dossier/-/registered-dossier/11665/7/6/2 (unpublished report).
   Google Scholar
• Anonymous. 1994. GLDA. https://echa.europa.eu/registration-dossier/-/registered-dossier/2174/7/7/2 (unpublished report).
   Google Scholar
• Anonymous. 1995a. GLDA. https://echa.europa.eu/registration-dossier/-/registered-dossier/2174/7/7/2/?documentUUID=11b419c0-93f6-48be-9219-03c63e21bdea (unpublished report).
   Google Scholar
• Anonymous. 1995b. GLDA. https://echa.europa.eu/registration-dossier/-/registered-dossier/2174/7/7/2/?documentUUID=9f9831e5-0b94-455f-940e-765801c906c3 (unpublished report).
   Google Scholar
• Anonymous. 1995c. GLDA. https://echa.europa.eu/registration-dossier/-/registered-dossier/2174/7/7/3 (unpublished report).
   Google Scholar
• Anonymous. 2007. GLDA. https://echa.europa.eu/registration-dossier/-/registered-dossier/2174/7/6/2. (unpublished report).
   Google Scholar
• Anonymous. 2012. EDG. https://echa.europa.eu/registration-dossier/-/registered-dossier/11665/7/7/2/?documentUUID=083532ed-fb5a-425a-bd3a-e1acd14b7d31 (unpublished report).
   Google Scholar
• Anonymous. 2014. GLDA. https://echa.europa.eu/registration-dossier/-/registered-dossier/2174/7/2/2 (unpublished report).
   Google Scholar
• BASF. 1995a. MGDA. https://echa.europa.eu/registration-dossier/-/registered-dossier/15592/7/7/2/?documentUUID=e5bfffa1-49fc-4fed-88a6-0d7c56dc7524 (unpublished report).
   Google Scholar
• BASF. 1995b. MGDA. https://echa.europa.eu/registration-dossier/-/registered-dossier/15592/7/7/2 (unpublished report).
   Google Scholar
• BASF. 1997a. NTA. https://echa.europa.eu/de/registration-dossier/-/registered-dossier/12171/7/6/2/?documentUUID=59c44e58-8f45-464d-8c67-65358e3cfcff.
   Google Scholar
• BASF. 1997b. MGDA. https://echa.europa.eu/registration-dossier/-/registered-dossier/15592/7/2/2/?documentUUID=c69c895d-8738-4d64-8336-68a42a2f35ad (unpublished report).
   Google Scholar
• BASF. 1997c. MGDA. https://echa.europa.eu/registration-dossier/-/registered-dossier/15592/7/7/3. (unpublished report).
   Google Scholar
• BASF. 1998a. NTA. https://echa.europa.eu/de/registration-dossier/-/registered-dossier/14301/7/6/2/?documentUUID=5a2c5947-5e1d-404d-a283-c2e6b1cbfc3c.
   Google Scholar
• BASF. 1998b. MGDA. https://echa.europa.eu/registration-dossier/-/registered-dossier/15592/7/6/2/?documentUUID=7180c783-d912-40eb-a5ce-3bcc6f8e8fcd (unpublished report)
   Google Scholar
• BASF. 2001. MGDA. https://echa.europa.eu/registration-dossier/-/registered-dossier/15592/7/7/2/?documentUUID=a471f4a3-07b2-4b74-a507-c1e2194b2a66 (unpublished report).
   Google Scholar
• BASF. 2003. NTA. https://echa.europa.eu/de/registration-dossier/-/registered-dossier/14301/7/6/2/?documentUUID=ea1c99fc-f84e-4f2e-9eb4-b32864edbc28.
   Google Scholar
• BASF. 2006. MGDA. https://echa.europa.eu/registration-dossier/-/registered-dossier/15592/7/8 (unpublished report).
   Google Scholar
• BASF. 2015. MGDA; https://echa.europa.eu/registration-dossier/-/registered-dossier/15592/7/2/2/?documentUUID=d1ea6ff9-93df-4a0c-93a0-bf73373e4217 (unpublished report).
   Google Scholar
• Begum ZA, Rahman IMM, Tate Y, Egawa Y, Maki T, Hasegawa H. 2012a. Formation and stability of binary complexes of divalent ecotoxic ions (Ni, Cu, Zn, Cd, Pb) with biodegradable aminopolycarboxylate chelants (dl-2-(2- carboxymethyl)nitrilotriacetic acid, GLDA, and 3-hydroxy-2,2 ′ -iminodisuccinic acid, HIDS) in aqueous solutions. J Sol Chem. 41(10):1713–1728. doi: 10.1007/s10953-012-9901-9.
   Web of Science ®Google Scholar
• Begum ZA, Rahman IMM, Sawai H, Tate Y, Maki T, Hasegawa H. 2012b. Stability constants of Fe(III) and Cr(III) complexes with dl-2-(2-carboxymethyl)nitrilotriacetic acid (GLDA) and 3-hydroxy-2,2′-iminodisuccinic acid (HIDS) in aqueous solution. J Chem Eng Data. 57(10):2723–2732. doi: 10.1021/je3005936.
   Web of Science ®Google Scholar
• Budny JA. 1972. Metabolism and blood pressure effects of disodium nitrilotriacetate (Na2NTA) in dogs. Toxicol Appl Pharmacol. 22(4):655–660. doi: 10.1016/0041-008x(72)90293-1.
   PubMed Web of Science ®Google Scholar
• Budny JA, Arnold JD. 1973. Nitrilotriacetate (NTA): human metabolism and its importance in the total safety evaluation program. Toxicol Appl Pharmacol. 25(1):48–53. doi: 10.1016/0041-008x(73)90161-0.
   PubMed Web of Science ®Google Scholar
• Budny JA, Niewenhuis RJ, Buehler EV, Goldenthal EI. 1973. Subacute oral toxicity of trisodium nitrilotriacetate (Na3NTA) in dogs. Toxicol Appl Pharmacol. 26(1):148–153. doi: 10.1016/0041-008x(73)90095-1.
   PubMed Web of Science ®Google Scholar
• Cohen N, Guilmette R. 1976. Biological effects of the enhanced excretion of Zinc after calcium diethylenetriaminepentaacetate chelation therapy. Bioinorg Chem. 5(3):203–210. doi: 10.1016/s0006-3061(00)82018-9.
   PubMedGoogle Scholar
• European Chemical Agency [ECHA]. 2017. Read-Across Assessment Framework (RAAF). https://echa.europa.eu/documents/10162/13628/raaf_en.pdf/614e5d61-891d-4154-8a47-87efebd1851a.
   Google Scholar
• European Chemical Agency [ECHA]. 2022. Assessment of regulatory needs (ARN)—group name: polycarboxylic acid monoamines, hydroxy derivatives and their salts with monovalent cations. https://echa.europa.eu/documents/10162/45dde3f2-73a7-e456-078c-7021a30da8cd.
   Google Scholar
• [EU] European Union. 2006. Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the registration, evaluation, authorisation and restriction of chemicals (REACH). https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A02006R1907-20140410.
   Google Scholar
• Foreman H, Vier M, Magee M. 1953. The metabolism of C14-labeled ethylenediaminetetraacetic acid in the rat. J Biol Chem. 203(2):1045–1053. doi: 10.1016/S0021-9258(19)52375-4.
   PubMed Web of Science ®Google Scholar
• Havlicek F. 1967. Metabolism and toxicity of therapeutic chelating agents. 3. Effect of EDTA and DTPA on the excretion of endogenous zinc. Strahlentherapie. 134(2):296–305.
   PubMedGoogle Scholar
• Goyer RA, Falk HL, Hogan M, Feldman DD, Richter W. 1981. Renal tumors in rats given trisodium nitrilotriacetic acid in drinking water for two years. J Natl Cancer Inst. 66(5):869–880.
   PubMedGoogle Scholar
• Harpur E, Ennulat D, Hoffman D, Betton G, Gautier JC, Riefke B, Bounous D, Schuster K, Beushausen S, Guffroy M, et al. 2011. Biological qualification of biomarkers of chemical-induced renal toxicity in two strains of male rats. Toxicol Sci. 122(2):235–252. doi: 10.1093/toxsci/kfr112.
   PubMed Web of Science ®Google Scholar
• The Hamner Institutes for Health Sciences [HIHS]. 2013. The comparative renal toxicity of NTA versus GLDA and other chelates using urinary biomarkers and renal cell proliferation as early predictors of nephrotoxicity. Report No. 12006B (unpublished report).
   Google Scholar
• Hoffmann D, Adler M, Vaidya VS, Rached E, Mulrane L, Gallagher WM, Callanan JJ, Gautier JC, Matheis K, Staedtler F, et al. 2010. Performance of novel kidney biomarkers in preclinical toxicity studies. Toxicol Sci. 116(1):8–22. doi: 10.1093/toxsci/kfq029.
   PubMed Web of Science ®Google Scholar
• The International Agency for Research on Cancer [IARC]. 1999. Nitrilotriacetic acid and its salts. IARC Monographs on the evaluation of carcinogenic risks to humans—some chemicals that cause tumours of the kidney or urinary bladder in rodents and some other substances. Vol. 73. Lyon, France: WHO; p. 385–399.
   Google Scholar
• Jayalakshmi S, Platel K. 2016. Compromised zinc status of experimental rats as a consequence of prolonged iron & calcium supplementation. Indian J Med Res. 143(2):238–244. doi: 10.4103/0971-5916.180221.
   PubMedGoogle Scholar
• Leibold E, Deckardt K, Mellert W, Potthoff-Karl B, Grundler O, Jäckh R. 2002. NTA and Fe(III)NTA: differential patterns of renal toxicity in subchronic studies. Hum Exp Toxicol. 21(8):445–452. doi: 10.1191/0960327102ht273oa.
   PubMed Web of Science ®Google Scholar
• Martell AE, Smith RM. 2004. Critically selected stability constants of metal complexes, version 8.0 (NIST standard reference database 46).
   Google Scholar
• Merski JA. 1982. Alterations of renal tissue structure during a 30-day gavage study with nitrilotriacetate. Food Chem Toxicol. 20(4):433–440. doi: 10.1016/s0278-6915(82)80109-9.
   PubMed Web of Science ®Google Scholar
• Michael WR, Wakim JB. 1971. Metabolism of nitrilotriacetic acid (NTA). Toxicol Appl Pharmacol. 18(2):407–416. doi: 10.1016/0041-008x(71)90133-5.
   PubMed Web of Science ®Google Scholar
• Michael WR, Wakim JB. 1973. Effect of trisodium nitrilotriacetate (Na3NTA) on the metabolism of selected metal ions. Toxicol Appl Pharmacol. 24(4):519–529. doi: 10.1016/0041-008x(73)90213-5.
   PubMed Web of Science ®Google Scholar
• Myers MC, Kanerva RL, Alden CL, Anderson RL. 1982. Reversibility of nephrotoxicity induced in rats by nitrilotriacetate in subchronic feeding studies. Food Chem Toxicol. 20(6):925–934. doi: 10.1016/S0015-6264(82)80230-7.
   PubMed Web of Science ®Google Scholar
• Natsch A, Adamsson G, Rocha V. 2023. ECHA ARN documents: chemical grouping without a toxicological rationale. Arch Toxicol. 97(5):1433–1437. doi: 10.1007/s00204-023-03479-3.
   PubMed Web of Science ®Google Scholar
• National Cancer Institute [NCI]. 1977. Bioassays of nitrilotriacetic acid (NTA) and nitrilotriacetic acid, trisodium salt, monohydrate (Na3NTA•H2O) for possible carcinogenicity. Testing Laboratory: Litton Bionetics Inc. Report No.: (NIH): 77-806.
   Google Scholar
• Nixon GA. 1971. Toxicity evaluation of trisodium nitrilotriacetate. Toxicol Appl Pharmacol. 18(2):398–406. doi: 10.1016/0041-008x(71)90132-3.
   PubMed Web of Science ®Google Scholar
• Nixon GA, Buehler EV, Niewenhuis RJ. 1972. Two-year rat feeding study with trisodium nitrilotriacetate and its calcium chelate. Toxicol Appl Pharmacol. 21(2):244–252. doi: 10.1016/0041-008x(72)90067-1.
   PubMed Web of Science ®Google Scholar
• National Research Council (US) [NRC]. 1995. Nutrient requirements of the laboratory rat–nutrient requirements of laboratory animals. 4th Rev ed. Washington, DC: Subcommittee on Laboratory Animal Nutrition, National Academies Press.
   Google Scholar
• National Cancer Institute (US) [NTIS]. 1977. Bioassay of trisodium ethylenediaminetetraacetate trihydrate (EDTA) for possible carcinogenicity. NTIS Technical Report Series No. 11.
   Google Scholar
• Ozer JS, Dieterle F, Troth S, Perentes E, Cordier A, Verdes P, Staedtler F, Mahl A, Grenet O, Roth DR, et al. 2010. A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function. Nat Biotechnol. 28(5):486–494. doi: 10.1038/nbt.1627.
   PubMed Web of Science ®Google Scholar
• Powell JJ, Burden TJ, Greenfield SM, Taylor PD, Thompson RP. 1999. Urinary excretion of essential metals following intravenous calcium disodium edetate: an estimate of free zinc and zinc status in man. J Inorg Biochem. 75(3):159–165. doi: 10.1016/s0162-0134(99)00054-9.
   PubMed Web of Science ®Google Scholar
• Rubin M, Martell AE. 1980. The implications of trace metal-nitrilotriacetic acid speciation on its environmental impact and toxicology. Biol Trace Elem Res. 2(1):1–19. doi: 10.1007/BF02789031.
   PubMed Web of Science ®Google Scholar
• Scientific Committee on Consumer Safety [SCCS]. 2010. Opinion on trisodium nitrilotriacetate (NTA). Report No.: SCCS/1391/10.
   Google Scholar
• Walker BE, Kelleher J. 1978. Plasma whole blood and urine zinc in the assessment of zinc deficiency in the rat. J Nutr. 108(10):1702–1707. doi: 10.1093/jn/108.10.1702.
   PubMed Web of Science ®Google Scholar
• Wohlleben W, Mehling A, Landsiedel R. 2023. Lessons learned from the grouping of chemicals to assess risks to human health. Angew Chem Int Ed Engl. 62(22):e20221065162. doi: 10.1002/anie.202210651.
   Google Scholar
• Wynn JE, Van’t Riet B, Borzelleca JF. 1970. The toxicity and pharmacodynamics of EGTA: oral administration to rats and comparisons with EDTA. Toxicol Appl Pharmacol. 16(3):807–817. doi: 10.1016/0041-008x(70)90087-6.
   PubMed Web of Science ®Google Scholar